Platform
Consulting
Resources
Pricing
Life Sciences Innovation Fund - Canada
Open

Life Sciences Innovation Fund

Money for human health related solutions
Last Update: March 4, 2026
Funding available
$ 500,000
Timeline
  • Open Date : January 26, 2023
Location
Canada

Overview

Access up to $500,000 in co-investment funding to take your human health related IP from the conceptual stage through to commercialization.

/100
Opportunity Score
Moderate potential, but conditions must align.

At a glance

Funding available

Financing goals
  • Launch or market a product/service
Eligible Funding
  • Maximum amount : 500,000 $
Timeline
  • Open Date : January 26, 2023

Eligible candidates

Eligible Industries
  • Professional, scientific and technical services
  • Health care and social assistance
Location
  • Canada
Legal structures
  • For-profit business
Annual revenue
  • All revenue ranges
Organisation size
  • All organization sizes
Audience
  • Startups

Next Steps

1
Determine your project
2
Validate your eligibility

Activities funded

This fund supports early-stage, Ontario-headquartered life sciences and healthcare technology companies in scaling their health solutions domestically and internationally. Eligible projects are focused on advancing innovation in areas critical to human health.

  • Scaling innovative solutions in cancer treatment.
  • Advancing developments in regenerative medicine.
  • Progressing neuroscience technologies.
  • Developing cutting-edge medical technologies.

Eligibility

Who is eligible?

Companies eligible for the Life Sciences Innovation Fund must be life sciences and healthcare technology companies related to human health. These companies need to be Ontario or Canadian incorporated for-profit entities with a headquarters in Ontario. They should be currently in the process of raising pre-seed or seed investments, with total round sizes ranging from $1 million to $5 million. Additionally, they must have raised less than $3 million in third-party capital.

Who is not eligible

There are specific types of companies that are not eligible to apply for the Life Sciences Innovation Fund (LSIF). These restrictions ensure that the fund is targeted towards companies that align with its mission.

  • OCI Ready for Market (R4M) Portfolio companies.

Eligible expenses

There are eligible expenses for this grant, including operating costs related to product development, research expenses, and commercialization activities.

  • Operating costs for product development
  • Research expenses
  • Commercialization activities

Eligible geographic areas

This grant is available to companies located in specific geographical areas determined by the funding body. The eligible locations are targeted to ensure alignment with regional development goals.

  • Companies that are Ontario or Canadian incorporated and headquartered in Ontario.

Additional information

Here are additional relevant details for this grant:

  • The Life Sciences Innovation Fund emphasizes the commercialization of Ontario-generated intellectual property, talent, and expertise.
  • Companies that are part of OCI's Ready for Market (R4M) portfolio are not eligible for this fund.
  • OCI co-invests alongside angel and other investors to mitigate risks and support startups in readiness for investors and customers.

Documents and links

Life Sciences Innovation Fund

Frequently Asked Questions about the Life Sciences Innovation Fund Program

Here are answers to the most common questions about the Life Sciences Innovation Fund. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.

What is the Life Sciences Innovation Fund?

Access up to $500,000 in co-investment funding to take your human health related IP from the conceptual stage through to commercialization.

How much funding can be received?

Life Sciences Innovation Fund Funds up to $500,000 of admissible expenses.

Who is eligible for the Life Sciences Innovation Fund program?

To be eligible for the Life Sciences Innovation Fund program, you must: Companies must be Ontario or Canadian incorporated for-profit entities headquartered in Ontario. Companies should be currently raising pre-seed or seed investments, with total round sizes ranging from $1 million to $5 million. Companies must have raised less than $3 million in third-party capital.

What expenses are eligible under Life Sciences Innovation Fund?

This fund supports early-stage, Ontario-headquartered life sciences and healthcare technology companies in scaling their health solutions domestically and internationally. Eligible projects are focused on advancing innovation in areas critical to human health. Scaling innovative solutions in cancer treatment. Advancing developments in regenerative medicine. Progressing neuroscience technologies. Developing cutting-edge medical technologies.

Who can I contact for more information about the Life Sciences Innovation Fund?

You can contact Ontario Centre of Innovation (OCI).

Where is the Life Sciences Innovation Fund available?

The Life Sciences Innovation Fund program is available across Canada.

Is the Life Sciences Innovation Fund a grant, loan, or tax credit?

Life Sciences Innovation Fund is a Grant and Funding